Sanofi US (FKA Sanofi-Aventis)
Registered Principal Details
Business Or Interest:
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Jez Moulding
Head
Pharmaceutical Manufacturing
Lobbying Interests:
All matters affecting the pharmaceuticals and health care industries.
CEO Name:
Jez Moulding
Head
Contact
DC
Deanne Calvert
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
deanne.calvert@sanofi.com
http://www.sanofi.us
1122 E. Pike Street, #1002
Seattle, WA 98122
(206) 320-0536
deanne.calvert@sanofi.com
http://www.sanofi.us
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|---|---|---|
Russell Sobotta | Exclusive Duties N/A | Authorized On 12/10/2016 | Withdrawn On N/A |
Jordan Lamb | Exclusive Duties N/A | Authorized On 1/2/2018 | Withdrawn On N/A |
Ronald W Kuehn | Exclusive Duties N/A | Authorized On 1/2/2018 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/12/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
11/22/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date11/22/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
2019-21 State Budget Bill
2019-21 State Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
The availability of the flu vaccine in hospitals and nursing homes
The availability of the flu vaccine in hospitals and nursing homes
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Health and immunization standards
Health and immunization standards
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Development, drafting or introduction of a proposal relating to
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Prevention and wellness initiatives
Prevention and wellness initiatives
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/30/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Biosimilars substitution
Biosimilars substitution
Action Intended To Affect
Legislative matter
Notification Date
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Meningococcal vaccine school entry requirement recommendations
Meningococcal vaccine school entry requirement recommendations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Biosimilars
Biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmaceuticals pricing
Pharmaceuticals pricing
Action Intended To Affect
Both Legislative matter and rule
Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2017 January - June $0.00 |
2017 July - December $12,057.50 |
2018 January - June $29,192.98 |
2018 July - December $13,273.20 |
Total $54,523.68 |
Total Hours Communicating | 2017 January - June 0.00 |
2017 July - December 27.50 |
2018 January - June 24.40 |
2018 July - December 9.00 |
Total 60.90 |
Total Hours Other | 2017 January - June 0.00 |
2017 July - December 13.00 |
2018 January - June 23.50 |
2018 July - December 8.70 |
Total 45.20 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December 30% |
2018 January - June 20% |
2018 July - December |
Total 21% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December 30% |
2018 January - June 20% |
2018 July - December |
Total 21% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December 10% |
2018 January - June |
2018 July - December 15% |
Total 6% |
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December 20% |
2018 January - June |
2018 July - December 25% |
Total 12% |
Rule making at the Wisconsin Department of Health Services to amend statewide immunization program pursuant to s. 252.04, Wis. Stats.
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December |
2018 January - June 50% |
2018 July - December 25% |
Total 27% |
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
---|---|---|---|---|
2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December 25% |
Total 4% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication